DLB vs IP: Which Is the Better Buy in 2026?
Last updated October 2026
Short answer
IP is the larger of the two ($18.03B market cap): the incumbent the market prices for continued execution (11.16x forward earnings, beta 0.89). DLB is the smaller challenger ($5.62B), actually pricier on forward earnings (13.09x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
DLB vs IP: the tie-breaker metrics
Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | DLB | IP | What it tells you |
|---|---|---|---|
| Market cap | $5.62B | $18.03B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 13.09 | 11.16 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Beta | 0.78 | 0.89 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 54% of range | 23% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 2.17 | 1.25 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: IP is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how DLB and IP affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. DLB and IP share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined DLB and IP exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Dolby Laboratories (DLB) do?
Dolby Laboratories licenses audio and imaging technologies to device makers, content creators, and distributors, earning royalties each time its formats are embedded in hardware or content. Its flagship brands (Dolby Atmos for immersive audio and Dolby Vision for HDR imaging) sit inside televisions, smartphones, PCs, set-top boxes, sound systems, streaming platforms, cinemas, and increasingly automotive infotainment. The model is asset-light: Dolby invests heavily in R&D and standardization, then monetizes the resulting patents and trademarks at very high gross margins once a format reaches critical mass.
What does International Paper (IP) do?
International Paper is a leading global producer of fiber-based packaging, pulp, and related products, best known for corrugated containers and the containerboard that goes into them. Its boxes carry everything from food and beverages to e-commerce shipments and industrial goods, so demand broadly tracks consumer and industrial activity. The company sells mainly to businesses rather than consumers, and its economics turn on containerboard pricing, box volumes, input costs like fiber and energy, and mill utilization. As a large, capital-intensive manufacturer, it competes on cost, scale, and its distribution and converting network.
DLB vs IP: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- DLB drivers: Atmos and Vision penetration; Automotive as a new surface.
- IP drivers: DS Smith integration and global scale; Cost cuts and footprint optimization.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Dolby's revenue is concentrated in patent and technology licensing, so expiring patents and the need to keep introducing successful new formats are structural risks to long-term royalty streams. For IP, the main risk is cyclicality: box volumes and containerboard pricing move with consumer and industrial activity, so an economic slowdown can reduce demand and pressure pricing and margins, as recent low-single-digit volume softness showed.
DLB or IP: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick DLB if you believe its drivers more; IP if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the DLB and IP guides.
DLB vs IP: the full fundamentals
DLB. Dolby trades at a mid-20s trailing GAAP earnings multiple that falls to about 13 times forward non-GAAP estimates (consensus near $4.58 per share for fiscal 2027). The valuation embeds a steady, high-margin licensing franchise with about $670 million of cash against minimal debt and trailing free cash flow of roughly $330 million, rather than a rapid grower. The fiscal fourth-quarter report on November 17, 2026 has a consensus near $1.20 per share on about $373 million of revenue.
IP. Figures are approximate and tied to the asOf date; verify live numbers before acting. With trailing GAAP results distorted by charges, International Paper is valued on cash flow and recovery estimates: about 0.75 times sales, roughly 7 times EBITDA and about 11 times 2027 consensus EPS, with a dividend yield near 5.4% that reflects both the low share price and investor doubt. The outcome for the EMEA business (sale price or spin-off) and the October 28, 2026 third-quarter report, where consensus looks for EPS of about $0.28 on $6.26 billion of revenue, matter more to the thesis than a single point-in-time multiple.
Headline figures (approximate, October 2026): DLB shows revenue (ttm) ~$1.35B; fiscal Q3 2026 ~$305M, down ~3% year over year, net income (ttm) ~$226M (FY2025 ~$255M), margins (ttm) Gross ~88%, operating ~12.6%, net ~16.7%, fiscal q3 2026 eps $0.69 non-GAAP vs ~$0.67 consensus; IP shows revenue (ttm) ~$24.2 billion; Q2 2026 ~$6.0 billion, down ~2% year over year, net income (ttm) ~-$2.7 billion on restructuring and impairment charges; Q2 2026 EPS $0.04 vs -$0.04 estimate, margins (ttm) Gross ~30%; operating ~2%, p/e No trailing P/E (loss); ~11x 2027 consensus EPS of ~$3.05.
The bottom line: DLB vs IP
DLB and IP are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined DLB and IP exposure against your real portfolio. It is not an investment adviser.
Wondering how DLB or IP fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Dolby Laboratories with AI
Connect the broker you already use and ask Walnut's AI how DLB fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between DLB and IP?
+
Dolby Laboratories licenses audio and imaging technologies to device makers, content creators, and distributors, earning royalties each time its formats are embedded in hardware or content. International Paper is a leading global producer of fiber-based packaging, pulp, and related products, best known for corrugated containers and the containerboard that goes into them. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is DLB or IP the better stock?
+
Neither is universally better. IP is the larger incumbent; DLB is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, DLB or IP?
+
On forward P/E (as of October 2026), DLB trades at 13.09x and IP at 11.16x, so IP is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both DLB and IP?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of DLB vs IP?
+
DLB: Dolby's revenue is concentrated in patent and technology licensing, so expiring patents and the need to keep introducing successful new formats are structural risks to long-term royalty streams. Results are exposed to consumer-electronics cyclicality and are lumpy because of periodic licensing true-ups and catch-up payments, which can swing quarterly comparisons meaningfully. A slowdown in TV, smartphone, or PC unit shipments would directly pressure royalties, and license renewals with major device makers can reset economics. Competition from Xperi/DTS, Sony, and other audio and imaging IP holders, plus the risk that a customer favors royalty-free or in-house alternatives, could erode share over time. Growth is modest, so multiple compression is a risk if the market expects more than mid-single-digit expansion. The June 2026 quarter, when revenue fell about 3% year over year and GAAP net income dropped to about $29 million, is a recent example of how uneven individual quarters can be. IP: The main risk is cyclicality: box volumes and containerboard pricing move with consumer and industrial activity, so an economic slowdown can reduce demand and pressure pricing and margins, as recent low-single-digit volume softness showed. The transformation adds substantial execution risk: integrating DS Smith, capturing synergies, and separating into two companies all carry costs, distraction, and the possibility of dis-synergies or delays. Heavy restructuring and impairment charges produced a trailing net loss of about $2.7 billion and continue to weigh on 2026 earnings even as they set up future savings. The dividend, at $1.85 a share and a yield near 5.4%, is far above trailing GAAP earnings, so its coverage depends on cash flow (about $1.65 billion of trailing free cash flow) and on the earnings recovery analysts expect. A sale of the European business at a discount to its purchase price would lock in value destruction from the DS Smith deal. Input costs for fiber, energy, and chemicals are volatile and can compress margins. The business is capital intensive and carries debt increased by the DS Smith deal, so higher rates raise financing costs. Trade policy, tariffs, and currency swings add further uncertainty across its now larger international footprint.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell DLB or IP; figures are approximate and dated (as of October 2026). Verify current data before investing.